Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Open Access
- 22 November 2022
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 19 (3) , 713-733
Abstract
The pro-inflammatory phase of bone healing, initiated by platelet activation and eventually hematoma formation, impacts bone marrow mesenchymal stromal cells (MSCs) in unknown ways. Here, we created platelet-rich plasma (PRP) hydrogels to study how platelet-derived factors modulate functional properties of encapsulated MSCs in comparison to a non-inflammatory fibrin (FBR) hydrogel environment. MSCs were isolated from human bone marrow, while PRP was collected from pooled apheresis thrombocyte concentrates and used for hydrogel preparation. After their encapsulation in hydrogels for 72 h, retrieved MSCs were analyzed for immunomodulatory activities, apoptosis, stem cell properties, senescence, CD9+, CD63+ and CD81+ extracellular vesicle (EV) release, and metabolism-related changes. PRP-hydrogels stimulated immunosuppressive functions of MSCs, along with their upregulated susceptibility to cell death in communication with PBMCs and augmented caspase 3/7 activity. We found impaired clonal growth and cell cycle progression, and more pronounced β-galactosidase activity as well as accumulation of LC3-II-positive vacuoles in PRP-MSCs. Stimuli derived from PRP-hydrogels upregulated AKT and reduced mTOR phosphorylation in MSCs, which suggests an initiation of survival-related processes. Our results showed that PRP-hydrogels might represent a metabolically stressful environment, inducing acidification of MSCs, reducing polarization of the mitochondrial membrane and increasing lipid accumulation. These features were not detected in FBR-MSCs, which showed reduced CD63+ and CD81+ EV production and maintained clonogenicity. Our data revealed that PRP-derived hematoma components cause metabolic adaptation of MSCs followed by increased immune regulatory functions. For the first time, we showed that PRP stimuli represent a survival challenge and “apoptotic priming” that are detrimental for stem cell-like growth of MSCs and important for their therapeutic consideration. Graphical AbstractKeywords
Funding Information
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (D-361)
- German Orthopedic and Orthopedic Surgery Society
- Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg (MD Excellence Program, MD Excellence Program)
- Julius-Maximilians-Universität Würzburg
This publication has 70 references indexed in Scilit:
- Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitroCytotherapy, 2013
- Platelet-rich plasma for managing pain and inflammation in osteoarthritisNature Reviews Rheumatology, 2013
- Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma modelCellular & Molecular Immunology, 2013
- Initial immune reaction and angiogenesis in bone healingJournal of Tissue Engineering and Regenerative Medicine, 2012
- Expansion of mesenchymal stem cells on fibrinogen-rich protein surfaces derived from blood plasmaJournal of Tissue Engineering and Regenerative Medicine, 2010
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences, 2008
- The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of boneThe Journal of Bone and Joint Surgery. British volume, 2008
- Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivoJournal of Experimental Medicine, 2006
- Caspases 3 and 7: Key Mediators of Mitochondrial Events of ApoptosisScience, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006